Angioplasty from bench to bedside to bench

Circulation

Volumn 93, Issue 9, 1996, Pages 1621-1629

  King III, Spencer B ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

angioplasty; balloon; coronary diesease; revascularization

Indexed keywords

ANGINA PECTORIS; ARTERY DIAMETER; CLINICAL PRACTICE; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; DEVICE; HEART INFARCTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REVIEW; STENT;

EID: 0029873029     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.9.1621     Document Type: Review

References (64)

1. Forssmann W. Die sonderrung des rechten Herzens. Klin Wehschr. 1929;8:2085-2087.
2. Cournand AF, Ranges HS. Catheterization of the right auricle in man. Proc Soc Exp Biol Med. 1941;46:462-466.
3. Cournand AF, Riley RL, Breed ES, Baldwin EF, Richards DW. Measurement of cardiac output in man using the technique of catheterization of the right auricle or ventricle. J Clin Invest. 1945; 24:106-116.
4. Sones FM Jr, Shirey EK, Proudfit WL, Wescott RN. Cine coronary arteriography. Circulation. 1959;20:773. Abstract.
5. Sones FM Jr, Shirey EK. Cine coronary arteriography. Mod Concepts Cardiovasc Dis. 1962;31:735-738.
6. Dotter CT, Rosch J, Judkins MP. Transluminal dilatation of atherosclerotic stenosis. Surg Gynecol Obstet. 1968;127:794-804.
7. Zeitler E, Schoop W, Zahnow W. The treatment of occlusive arterial disease by transluminal catheter angioplasty. Radiology. 1971;99:19-26.
8. Porstmann W. Ein neuer Korsett-Ballonkatheter zur transluminalen Rekanalisation nach Dotter unter besonderer Berucksichtigung von Obliterationen an den Beckenarterien. Radiol Diagn. 1973;14:239-243.
9. Gruentzig A, Turina M, Schneider J. Experimental percutaneous dilatation of coronary artery stenosis. Circulation. 1976;54:81. Abstract.
10. Meier B, Zum IO. Todestag von Andreas R. Grüntzig (1939-1985). Schweiz Aerztezeitung. 1995;76:1989-1992.
11. Hurst JW. History of coronary catheterization. In: King SB III, Douglas JS Jr, eds. Coronary Arteriography and Angioplasty. New York, NY: McGraw-Hill Publishing Co Inc; 1985:6-8.
12. Grüntzig A. Transluminal dilatation of coronary artery stenosis. Lancet. 1978;1:263. Letters.
13. Gruentzig A, Senning A, Siegenthaler W. Nonoperative dilatation of coronary artery stenosis: percutaneous transluminal coronary angioplasty (PTCA). N Engl J Med. 1979;301:61-68.
14. Gruentzig A, Myler R, Hanna R, Turina M. Coronary transluminal angioplasty. Circulation. 1977;56:84. Abstract.
15. Ischinger T, Gruentzig AR, Hollman J, King SB, Douglas JS, Meier B, Bradford J, Tankersley R. Should coronary arteries with less than 60% diameter stenosis be treated by angioplasty? Circulation. 1983;68:148-154.
16. Douglas JS, Gruentzig AR, King SB, Hollman J, Ischinger T, Meier B, Craver JM, Jones EL, Waller JL, Bone DK, Guyton R. Percutaneous transluminal coronary angioplasty in patients with prior coronary bypass surgery. J Am Coll Cardiol. 1983;2:745-754.
17. Hollman J, Gruentzig AR, Douglas JS, King SB, Ischinger T, Meier B. Acute occlusion after percutaneous transluminal coronary angioplasty: a new approach. Circulation. 1983;68:725-735.
18. Thornton MA, Gruentzig AR, Hollman J, King SB, Douglas JS. Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study. Circulation. 1984;69:721-727.
19. Meier B, King SB, Gruentzig AR, Douglas JS, Hollman J, Ischinger T, Galan K, Tankersley R. Repeat coronary angioplasty. J Am Coll Cardiol. 1984;4:463-466.
20. Bredlau C, Roubin GS, Leimgruber PP, Douglas JS, King SB, Gruentzig AR. In-hospital morbidity and mortality in elective coronary angioplasty. Circulation. 1985;72:1044-1052.
21. Anderson HV, Roubin GS, Leimgruber PP, Douglas JS, King SB, Gruentzig AR. Primary angiographic success rates of percutaneous transluminal coronary angioplasty. Am J Cardiol. 1985;56:712-717.
22. Leimgruber PP, Roubin GS, Anderson HV, Bredlau C, Whitworth H, Douglas JS, King SB, Gruentzig AR. Influence of intimal dissection on restenosis after successful angioplasty. Circulation. 1985; 72:530-535.
23. Anderson HV, Roubin GS, Leimgruber PP, Cos WR, Douglas JS, King SB, Gruentzig AR. Transstenotic pressure gradient measurements during percutaneous transluminal coronary angioplasty. Circulation. 1986;73:1223-1230.
24. Leimgruber P, Roubin GS, Hollman J, Cotsonis GA, Meier B, Douglas JS, King SB, Gruentzig AR. Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation. 1986;73:712-717.
25. Roubin GS, Douglas JS, King SB. Percutaneous coronary angioplasty: influence of operator experience on results. Am J Cardiol. 1986;57:873-874. Editorial.
26. Whitworth HB, Roubin GS, Hollman J, Meier B, Leimgruber PP, Douglas JS, King SB, Gruentzig AR. Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1986;8:1271-1276.
27. Meier B, Gruentzig A, Hollman J, Ischinger T, Bradford JM. Does length or eccentricity of coronary stenosis influence the outcome of transluminal dilatation? Circulation. 1983;67:497-499.
28. Levy RI, Mock MB, William VL, Frommer PL. Percutaneous transluminal coronary angioplasty. N Engl J Med. 1979;301:101-103. Editorial.
29. Proceedings of the National Heart, Lung, and Blood Institute Workshop on the Outcome of Percutaneous Transluminal Coronary Angioplasty. Am J Cardiol. 1984;53(special issue):1C-146C.
30. Hartzler GO, Rutherford BD, McConahay DR, McCallister SH. Simultaneous multiple lesion coronary angioplasty: a preferred therapy for patients with multiple vessel disease. Circulation. 1982; 16(suppl II):II-5. Abstract.
31. Hartzler GO. Percutaneous transluminal coronary angioplasty in multivessel disease. Cathet Cardiovasc Diagn. 1983;9:537-541.
32. Meyer J, Merx W, Schmitz H, Erbel R, Kiesslich T, Dorr R, Lambertz H, Bethge C, Krebs W, Bardos P, Minale C, Messmer BJ, Effert S. Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transmural myocardial infarction. Circulation. 1982;66:905-913.
33. King SB III, Lembo NJ, Weintraub WS, Kosinski AS, Barnhart HX, Kutner MH, Alazraki NP, Guyton RA, Zhao XQ, for the Emory Angioplasty versus Surgery Trial (EAST). A randomized trial comparing coronary angioplasty with coronary bypass surgery. N Engl J Med. 1994;331:1044-1050.
34. King SB III, Lembo NJ, Weintraub WS, Kosinski AS, Barnhart HX, Kutner MH, for the EAST Investigators. Emory angioplasty versus surgery trial (EAST): design, recruitment, and baseline description of patients. Am J Cardiol. 1995;75:42C-59C.
35. Simpson JB, Johnson DE, Thapliyal HV, Marks DM, Braden LJ. Transluminal atherectomy: a new approach to the treatment of atherosclerotic vascular disease. Circulation. 1985;72(suppl III): III-146. Abstract.
36. Rowe MH, Hinohara T, White NW, Robertson GC, Selmon MR, Simpson JB. Comparison of dissection rates and angiographic results following directional coronary atherectomy and coronary angioplasty. Am J Cardiol. 1990;66:49-53.
37. Hansen D, Auth D, Hall M, Ritchie J. Rotational endarterectomy in normal canine coronary arteries: preliminary report. J Am Coll Cardiol. 1988;11:1073-1077.
38. Roubin GS, Robinson KA, King SB, Gianturco C, Black A, Brown JE, Siegel RJ, Douglas JS. Early and late results of intracoronary arterial stenting after coronary angioplasty in dogs. Circulation. 1987;76:891-897.
39. Palmaz JC, Sibbet RR, Reuter SR, Tio FO, Rice WJ. Expandable intra-luminal graft: a preliminary study. Radiology. 1985;156:73-77.
40. Topol EJ, Leya F, Pinkerton CA, Whitlow PL, Hofling B, Simonton CA, Masden RR, Serruys PW, Leon MB, Williams DO, King SB III, Mark DB, Isner JM, Holmes DR Jr, Ellis SG, Lee KL, Keeler GP, Berdan LG, Hinohara T, Califf RM, for the CAVEAT Study Group. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med. 1993;329:221-227.
41. Fourrier JL, Bertrand ME, Auth DC, Lablanche JM, Gommeaux A, Brunetaud JM. Percutaneous coronary rotational angioplasty in humans: preliminary report. J Am Coll Cardiol. 1989;14:1278-1282.
42. Litvack F, Eigler N, Margolis J, Rothbaum D, Bresnahan JF, Holmes D, Untereker W, Leon M, Kent K, Pichard A, King S, Ghazzal Z, Cummins F, Krauthamer D, Palacios I, Block P, Hartzler GO, O'Neill W, Cowley M, Roubin G, Klein LW, Frankel PS, Adams C, Goldenberg T, Laudenslager J, Grundfest WS, Forrester JS, for the ELCA Investigators. Percutaneous excimer coronary angioplasty: results in the first consecutive 3000 patients. J Am Coll Cardiol. 1994;23:323-329.
43. Bourassa MG, Roubin GS, Detre KM, Sopko G, Krone RJ, Attabuto MJ, Bjerregaad P, Bolling S, Herman MV, Frye R, and the BARI Study Group. Bypass angioplasty revascularization investigation: patient screening, selection, and recruitment. Am J Cardiol. 1995;75:3C-8C.
44. Pocock SJ, Henderson RA, Rickards AF, Hampton JR, King SB III, Hamm CW, Puel J, Hueb W, Goy J-J, Rodriguez A. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet. 1995;346:1184-1189.
45. CABRI Trial Participants. First-year results of CABRI (Coronary Angioplasty vs Bypass Revascularisation Investigation). Lancet. 1995;346:1179-1184.
46. RITA Trial Participants. Coronary angioplasty versus coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial. Lancet. 1993;343:573-580.
47. Hamm CW, Riemers J, Ischinger T, Rupprecht HJ, Berger J, Bleifeld W. A randomised study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. N Engl J Med. 1994;331:1037-1043.
48. Puel J, Karouny E, Marco F, Assoun B, Galinier M, Elbaz M, Alibelli MJ, Bounhoure JP. Angioplasty versus surgery in multivessel disease: immediate results and in-hospital outcome in a randomized prospective study. Circulation. 1992;86(suppl I):I-372. Abstract.
49. Hueb WA, Bellotti G, de Oliveira SA, Arie S, de Albuquerque CP, Jatene AD, Pileggi F. The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. J Am Coll Cardiol. 1995;26: 1600-1605.
50. Goy J-J, Eeckhout E, Burnand B, Vogt P, Stauffer JC, Hurni M, Stumpe F, Ruchat P, Sadeghi H, Kappenberger L. Coronary angioplasty versus left internal mammary grafting for isolated proximal left anterior descending artery stenosis. Lancet. 1994;343: 1449-1453.
51. Rodriguez A, Boullon F, Perez-Balino N, Paviotti C, Liprandi MIS, Palacios I, on behalf of the ERACI Group. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. J Am Coll Cardiol. 1993;22: 1060-1067.
52. The MERCATOR Study Group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR Study: a multicenter, randomized, double-blind placebo-controlled trial. Circulation. 1992;86:100-110.
53. Serruys PW, Rutsch W, Heyndrickx G, Danchin N, Mast G, Wijns W, Rensing BJ. for the CARPORT Study Group. Effect of long term thromboxane A2 receptor blockade on angiographic restenosis and clinical events after coronary angioplasty: the CARPORT study. J Am Coll Cardiol. 1991;17:283. Abstract.
54. Santoian EC, Schneider JE, Gravanis MB, Foegh M, Tarazona N, Cipolla G, King SB III. Angiopeptin inhibits intimal hyperplasia after angioplasty in porcine coronary arteries. Circulation. 1993;88: 11-14.
55. Weintraub WS, Boccuzzi SJ, Klein JL, Kosinski AS, King SB III, Ivanhoe R, Cedarholm JC, Stillabower ME, Talley JD, DeMaio SJ, O'Neill WW, Frazier JE II, Cohen-Bernstein CL, Robbins DC, Brown CL III, Alexander RW, and the Lovastatin Restenosis Trial Study Group. Lack of effect of lovastatin on restenosis after coronary angioplasty. N Engl J Med. 1994;331:1331-1337.
56. Dehmer GJ, Popma JJ, van den Berg EK, Eichhorn EJ, Prewitt JB, Campbell WB, Jennings L, Willerson JT, Schmitz JM. Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N Engl J Med. 1988;319:733-740.
57. Reis GJ, Boucher TM, Sipperly ME, Silverman DI, McCabe CH, Baim DS, Sacks FM, Grossman W, Pasternak RC. Randomized trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet. 1989;2:177-181.
58. Maresta A, Balducelli M, Cantini L, Casari A, Chioin R, Fabbri M, Fontanelli A, Preti PAM, Repetto S, De Servi S, Varani E, for the STARC Investigators. Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty: results of the randomized, double-blind STARC study. Circulation. 1994;90:2710-2715.
59. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med. 1994;330:956-961.
60. Weidermann JG, Marboe C, Schwartz A, Amols H, Weinberger J. Intracoronary irradiation reduces restenosis after balloon angioplasty in a porcine model. J Am Coll Cardiol. 1994;23:1491-1498.
61. Waksman R, Robinson KA, Crocker IR, Wang C, Gravanis MB, Cipolla GD, Hillstead RA, King SB III. Intracoronary low-dose β-irradiation inhibits neointima formation after coronary artery balloon injury in the swine restenosis model. Circulation. 1995;92: 3025-3031.
62. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish RD, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S, for the Stent Restenosis Study Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331: 496-501.
63. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J, Morel M-A, for the BENESTENT Study Group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489-495.
64. Serruys PW, on behalf of the Benestent II-Pilot Study Group. Benestent-II Pilot Study: 6 months follow-up of phase 1, 2, and 3. Circulation. 1995;92(suppl):I-542. Abstract.